Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-02-08

Clinical Trial Update: Safety Study of Live Attenuated Oral Shigella (WRSS1) Vaccine in Bangladeshi Adults and Children [NA]

View source ↗

Summary

Safety study of the WRSS1 live attenuated oral Shigella vaccine in Bangladeshi adults and children completed, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • WRSS1 live attenuated oral Shigella vaccine (WRSS1)

Snippet

Sponsor: PATH | Conditions: Diarrhea | NA | Status: COMPLETED | Results posted: 2019-02-08